EGFR and neoplasm: In addition, we performed paired analysis of RNA sequencing and IHC data of patient-derived tumor xenograft (PDX) samples, and estimated that EGFR and MUC1 were expressed in 97.5% of LUAD samples of The Cancer Genome Atlas Program (TCGA) database.